133 related articles for article (PubMed ID: 1558398)
1. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group].
Taguchi T; Wakui A; Nabeya K; Kurihara M; Isono K; Kakegawa T; Ota K
Gan To Kagaku Ryoho; 1992 Apr; 19(4):483-8. PubMed ID: 1558398
[TBL] [Abstract][Full Text] [Related]
2. [An early phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].
Inuyama Y; Miyake H; Horiuchi M; Hayasaki K; Komiyama S; Ota K
Gan To Kagaku Ryoho; 1992 Jun; 19(6):863-9. PubMed ID: 1605664
[TBL] [Abstract][Full Text] [Related]
3. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for advanced breast cancer].
Koyama H; Ogawa M; Kuraishi Y; Tominaga K; Yoshida M; Taguchi T
Gan To Kagaku Ryoho; 1992 Jul; 19(7):1049-53. PubMed ID: 1626940
[TBL] [Abstract][Full Text] [Related]
4. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus].
Noda K; Ikeda M; Yakushiji M; Nishimura H; Terashima Y; Sasaki H; Hata T; Kuramoto H; Tanaka K; Takahashi T
Gan To Kagaku Ryoho; 1992 Jun; 19(6):885-92. PubMed ID: 1605666
[TBL] [Abstract][Full Text] [Related]
5. [A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].
Inuyama Y; Miyake H; Horiuchi M; Hayasaki K; Komiyama S; Ota K
Gan To Kagaku Ryoho; 1992 Jun; 19(6):871-7. PubMed ID: 1605665
[TBL] [Abstract][Full Text] [Related]
6. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer].
Furuse K; Fukuoka M; Kurita Y; Ariyoshi Y; Niitani H; Yoneda S; Fujii M; Hasegawa K; Nishiwaki Y; Tamura M
Gan To Kagaku Ryoho; 1992 Jun; 19(6):879-84. PubMed ID: 1318698
[TBL] [Abstract][Full Text] [Related]
7. [Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer].
Kato T; Nishimura H; Yakushiji M; Noda K; Terashima Y; Takeuchi S; Takamizawa H; Suzuki M; Arai M; Ota M
Gan To Kagaku Ryoho; 1992 May; 19(5):695-701. PubMed ID: 1580643
[TBL] [Abstract][Full Text] [Related]
8. [Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)].
Ota K; Wakui A; Majima H; Niitani H; Inuyama Y; Ogawa M; Ariyoshi Y; Yoshida O; Taguchi T; Kimura I
Gan To Kagaku Ryoho; 1992 Jun; 19(6):855-61. PubMed ID: 1605663
[TBL] [Abstract][Full Text] [Related]
9. [Phase II study of carboplatin in head and neck cancer].
Inuyama Y; Togawa K; Morita M; Takeoda S; Kaneko T; Takemiya S; Ono I; Nomura Y; Okuda M; Kikuchi K
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2131-8. PubMed ID: 3293536
[TBL] [Abstract][Full Text] [Related]
10. [A phase II study of carboplatin in small cell lung cancer].
Komatsu H; Furuse K; Nishikawa H; Minoda S; Saotome K; Nemoto E; Tani Y; Saito T; Ishiwata K; Tsutsumi M
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2313-8. PubMed ID: 2841905
[TBL] [Abstract][Full Text] [Related]
11. Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion.
Sasaki Y; Amano T; Morita M; Shinkai T; Eguchi K; Tamura T; Ohe Y; Kojima A; Saijo N
Cancer Res; 1991 Mar; 51(5):1472-7. PubMed ID: 1997185
[TBL] [Abstract][Full Text] [Related]
12. [Ototoxicity of cis-diammine glycolato platinum, 254-S].
Horiuchi M; Miyake H; Ota K
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1327-32. PubMed ID: 1503488
[TBL] [Abstract][Full Text] [Related]
13. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
Taguchi T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
[TBL] [Abstract][Full Text] [Related]
14. A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.
Sato Y; Takayama T; Sagawa T; Okamoto T; Miyanishi K; Sato T; Araki H; Iyama S; Abe S; Murase K; Takimoto R; Nagakura H; Hareyama M; Kato J; Niitsu Y
Cancer Chemother Pharmacol; 2006 Nov; 58(5):570-6. PubMed ID: 16463059
[TBL] [Abstract][Full Text] [Related]
15. Treatment of patients with upper gastrointestinal carcinomas.
Ajani JA
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
[TBL] [Abstract][Full Text] [Related]
16. [Phase II study of cisplatin in esophageal carcinoma].
Nishihira T; Abo S; Mori S; Isono K; Endo M; Iizuka T; Fujimaki M; Sugimachi K; Kakegawa T; Kasai M
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2939-46. PubMed ID: 3767386
[TBL] [Abstract][Full Text] [Related]
17. [Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].
Xu RH; Shi YX; Guan ZZ; Jiang WQ; Huang H; Ma ZY; Wang JH; Hu XH; Xie WM; Li XG; Liu YL; Pan LX; Dai AD; Zhuang W; Zhang C
Ai Zheng; 2006 Dec; 25(12):1565-8. PubMed ID: 17166388
[TBL] [Abstract][Full Text] [Related]
18. [Phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in gastrointestinal cancer].
Takenaka K; Tamada R; Hiramoto Y; Inokuchi K; Saku M; Oka N; Kano T; Noda S; Nagasaki S; Toda T
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2155-60. PubMed ID: 4062315
[TBL] [Abstract][Full Text] [Related]
19. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
Dragovich T; Mendelson D; Kurtin S; Richardson K; Von Hoff D; Hoos A
Cancer Chemother Pharmacol; 2006 Dec; 58(6):759-64. PubMed ID: 16847673
[TBL] [Abstract][Full Text] [Related]
20. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
